about
Algae-produced Pfs25 elicits antibodies that inhibit malaria transmissionHuman leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon.Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic LeptospiraAmazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategiesMutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone AntimalarialsPlasmodium ookinete-secreted proteins secreted through a common micronemal pathway are targets of blocking malaria transmissionEvidence-based annotation of the malaria parasite's genome using comparative expression profilingA systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito[Seroprevalence of leptospirosis in Puente Piedra, Lima, in 2006].Whole genome sequencing analysis of Plasmodium vivax using whole genome captureComparative analysis of severe pediatric and adult leptospirosis in Sao Paulo, Brazil.Regional differences of leptospirosis in Sri Lanka: observations from a flood-associated outbreak in 2011.The contribution of bats to leptospirosis transmission in Sao Paulo City, Brazil.Asymptomatic renal colonization of humans in the peruvian Amazon by LeptospiraLarge scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.A protein-conjugate approach to develop a monoclonal antibody-based antigen detection test for the diagnosis of human brucellosisIntermittent preventive treatment for malaria in sub-saharan African: a halfway technology or a critical intervention?Engineered resistance to Plasmodium falciparum development in transgenic Anopheles stephensi.Micronemal transport of Plasmodium ookinete chitinases to the electron-dense area of the apical complex for extracellular secretionDisruption of Plasmodium falciparum chitinase markedly impairs parasite invasion of mosquito midgut.KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.Identification of novel Plasmodium gallinaceum zygote- and ookinete-expressed proteins as targets for blocking malaria transmission.Plasmodium ookinete-secreted chitinase and parasite penetration of the mosquito peritrophic matrix.Leptospirosis: a zoonotic disease of global importance.Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burdenIn vitro generation of Plasmodium falciparum ookinetes.Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genesExpression of sialic acids and other nonulosonic acids in LeptospiraPlasmodium falciparum field isolates from South America use an atypical red blood cell invasion pathway associated with invasion ligand polymorphisms.Whole genome analysis of Leptospira licerasiae provides insight into leptospiral evolution and pathogenicity.Ex vivo innate immune cytokine signature of enhanced risk of relapsing brucellosisPathogenomic inference of virulence-associated genes in Leptospira interrogans.A cluster of cutaneous leishmaniasis associated with human smugglingOutpatient follow-up of patients hospitalized for acute leptospirosis.Phenotyping clinical resistance to chloroquine in Plasmodium vivax in northeastern Papua, IndonesiaLack of molecular correlates of Plasmodium vivax ookinete development.Characteristics of rural leptospirosis patients admitted to referral hospitals during the 2008 leptospirosis outbreak in Sri Lanka: implications for developing public health control measuresLeptospirosis outbreak in Sri Lanka in 2008: lessons for assessing the global burden of disease.Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans.
P50
Q21134576-044FC821-F74F-4573-82C5-B3EBE9951AD2Q21144549-A640EA28-8E58-4E31-8E31-4AB62ED34CF2Q21144700-9F1584F7-1DCE-42C1-83CD-011AF248042FQ26860062-30BAC219-559F-402F-BA6B-6B4D9D801A83Q27861952-FFA42B21-8658-49EE-8D4C-0541803E6CDCQ27974514-C9BC642A-77BC-429C-B12D-9762C57666B9Q28472095-363D6606-219B-4BCC-8DF9-6B6B6D4F3BE8Q28473572-3BDCC4B1-F444-4771-B949-739D8495C78BQ30454122-FDB65CB5-A9B3-4CD1-97BB-D2BFD25A1E05Q30464966-1CC34DC2-BB63-4B67-B0A3-7465CF105A8FQ33399475-3C85632D-F400-4B72-AFB2-2BB2A90FE220Q33412837-D60194C2-D71B-46A4-9FBF-85D4E2DB92D2Q33529584-2E0A059A-7195-4C1E-853B-F2F50E2380DAQ33534675-82732B58-2CBA-4A9A-82D7-E5DF28CF5D16Q33573403-DF37AF81-70C4-4969-A783-388E757AA7AAQ33707032-621E3E16-04F4-411B-B908-1023C88EE4A1Q33716740-D3D7E805-A786-4111-895F-BB569B56E09EQ33817498-C993CE9E-2348-4817-84E6-B6B49748E7FDQ33886121-8C543738-5A03-4E3A-944E-324B837D6DA4Q34005064-95356FF8-858B-4B2D-B98C-696F9EC99EB7Q34008076-BD6B11F6-A9D8-4A8C-9EA2-A0F4263CFE1CQ34057433-30795453-DA41-4CA4-A718-91F8C9D4D533Q34116333-24EA9AC9-1179-450A-8DD2-08A7A4957823Q34264709-D328E2FA-F7BA-4B89-BF78-05BB9293B1EAQ34280573-EB68F960-C18B-4703-8000-8D5A940AC41EQ34334413-90A0FC72-4F8C-457F-B065-645F8AFA5CC0Q34341749-6E40F110-1E57-4395-A5AA-840A07E4FA2AQ34359141-6CC58114-9D46-4864-89BA-024A2E2270D7Q34361920-C94D36E2-91B4-4F30-B70F-6F9CDD7EB59FQ34464648-E467113E-1214-4F7D-8F7A-628CE0486243Q34474564-CD86FC66-9AC2-4FFC-AA92-27DA5AA28E81Q34990707-1AB49A52-7443-42FF-AEC4-D2247132BD02Q35010450-347C3E64-AA70-4A54-A2D4-22620188E7B8Q35031892-56A36D5F-E65D-47B8-9BCC-515A6C93CB40Q35053253-F1552C1C-2658-440D-9F5D-B997B9A5F461Q35095652-2F7811D2-5852-4B6D-9793-82AC2918D1AEQ35131352-87627737-D3B5-483A-B763-C6389FC29FBDQ35140552-D313F7D1-CF43-4EE4-AE5C-E061392DA72BQ35186824-FFA591C9-73A7-46E2-9ECE-A3422E9D08B1Q35296643-AF8F7031-BCAE-4AFC-A080-8DB3E6BA8AC6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joseph M Vinetz
@nl
Joseph M Vinetz
@sl
Joseph M. Vinetz
@en
Joseph M. Vinetz
@es
Joseph Vinetz
@fr
type
label
Joseph M Vinetz
@nl
Joseph M Vinetz
@sl
Joseph M. Vinetz
@en
Joseph M. Vinetz
@es
Joseph Vinetz
@fr
prefLabel
Joseph M Vinetz
@nl
Joseph M Vinetz
@sl
Joseph M. Vinetz
@en
Joseph M. Vinetz
@es
Joseph Vinetz
@fr
P1153
7003519222
P21
P31
P496
0000-0001-8344-2004